PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer
Clinical trial NCT00605397 · COMPLETED
Trial details
- NCT number
- NCT00605397
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.